Long-term neuropsychiatric symptoms as well as neurologic and functional impairment are common in patients who receive extracorporeal membrane oxygenation (ECMO) support, results of a new ...
In the current issue of Polish Archives of Internal Medicine (Pol Arch Intern Med), Celińska‑Spodar et al 6 presented a retrospective review of their tertiary center’s experience with VA ECMO. The ...
In patients with acute MI complicated by cardiogenic shock (AMICS) who are slated to undergo early revascularization, routine use of extracorporeal membrane oxygenation (ECMO) doesn’t reduce 30-day ...
At 60 days, 44 of 124 patients (35%) in the ECMO group and 57 of 125 (46%) in the control group had died (relative risk, 0.76; 95% confidence interval [CI], 0.55 to 1.04; P=0.09). Crossover to ECMO ...
Please provide your email address to receive an email when new articles are posted on . A protocol with extracorporeal membrane oxygenation-facilitated resuscitation improved survival in patients with ...
Patients with severe COVID-19 who require venovenous extracorporeal membrane oxygenation (VV-ECMO) support can, if carefully selected and managed, obtain “exceptional survival” approaching 87% at 1 ...
Extracorporeal membrane oxygenation (ECMO) is a supportive therapy for adults, including during or soon after pregnancy, with severe acute respiratory failure from a potentially reversible cause.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results